ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 162 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $195 | -69.1% | 122,676 | -86.1% | 0.02% | -69.4% |
| Q1 2023 | $631 | +31.2% | 879,684 | +5.9% | 0.06% | +3.3% |
| Q4 2022 | $481 | -99.4% | 830,829 | +950.7% | 0.06% | +500.0% |
| Q3 2022 | $75,000 | -85.5% | 79,076 | -80.0% | 0.01% | -85.7% |
| Q1 2022 | $518,000 | -43.6% | 395,585 | -24.3% | 0.07% | -39.1% |
| Q4 2021 | $919,000 | +665.8% | 522,284 | +4378.9% | 0.12% | +475.0% |
| Q3 2020 | $120,000 | -36.2% | 11,661 | -28.4% | 0.02% | -9.1% |
| Q4 2019 | $188,000 | +108.9% | 16,278 | +10.0% | 0.02% | +340.0% |
| Q3 2018 | $90,000 | – | 14,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 6,552,068 | $14,218,000 | 8.03% |
| Versant Venture Management, LLC | 5,068,233 | $10,998,000 | 4.55% |
| K2 PRINCIPAL FUND, L.P. | 1,653,874 | $3,589,000 | 0.29% |
| RTW INVESTMENTS, LP | 7,483,757 | $16,240,000 | 0.24% |
| Avoro Capital Advisors LLC | 6,950,000 | $15,082,000 | 0.24% |
| Artal Group S.A. | 3,000,000 | $6,510,000 | 0.15% |
| ALGERT GLOBAL LLC | 231,490 | $502,000 | 0.07% |
| Virtus ETF Advisers LLC | 57,768 | $125,000 | 0.06% |
| Pinz Capital Management, LP | 53,600 | $116,000 | 0.05% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 100,000 | $217,000 | 0.05% |